How Does Zoely Work in the Body
Chemical Composition, Mechanism of Action & Metabolic Effects Explained
Key Takeaways: How Zoely Works
- Active Ingredients: Nomegestrol acetate (2.5 mg, progestogen) and estradiol (1.5 mg, bioidentical oestrogen).
- Primary Actions: Prevents ovulation by suppressing LH surge, thickens cervical mucus to block sperm, and alters endometrium to inhibit implantation.
- Onset & Duration: Full contraceptive protection starts immediately if taken on day 1 of menstruation; otherwise after 7 days. Steady state achieved within 5–7 days.
- Metabolism: Both hormones are metabolised in the liver (CYP3A4 main pathway); nomegestrol acetate has a long half‑life (~46 hours) allowing a 24‑hour dosing window.
- Cycle Control: 24 active tablets + 4 placebo tablets mimic a natural 28‑day cycle with predictable withdrawal bleeding.
Zoely is a modern combined hormonal contraceptive that uses a bioidentical oestrogen (estradiol) together with the selective progestogen nomegestrol acetate to provide reliable pregnancy prevention while maintaining good cycle control. Its dual‑action mechanism targets the hypothalamic‑pituitary‑ovarian axis, cervical mucus, and the endometrium to achieve high contraceptive efficacy.
Important Medical Advice
If you experience any signs of a blood clot (deep vein thrombosis: swelling, pain, warmth in one leg; pulmonary embolism: sudden breathlessness, sharp chest pain; heart attack: chest pain radiating to arm; stroke: sudden weakness, confusion, vision loss), seek urgent medical attention immediately. Also contact your doctor if you develop severe abdominal pain, breast lumps, or unexplained heavy vaginal bleeding while using Zoely.
Chemical Composition & Molecular Structure
Zoely film‑coated tablets contain two active hormonal substances: nomegestrol acetate (2.5 mg) and estradiol (1.5 mg as hemihydrate). Each blister provides 24 white active tablets and 4 yellow placebo tablets (without hormones). The excipient includes lactose monohydrate, microcrystalline cellulose, and other pharmaceutical agents that ensure tablet stability and bioavailability.
Structural Details
(17α)-17-(acetyloxy)-6-methyl-19-norpregna-4,6-diene-3,20-dione
A 19‑norprogesterone derivative with high progestogenic potency and antiandrogenic properties. It binds selectively to progesterone receptors with minimal off‑target glucocorticoid or mineralocorticoid activity. Its acetate ester improves oral bioavailability.
estra-1,3,5(10)-triene-3,17β-diol
Bioidentical to the endogenous oestrogen produced by human ovaries. Unlike ethinylestradiol used in most combined pills, estradiol is rapidly metabolised to estrone and estriol, which have a shorter half‑life and a more physiological oestrogenic profile.
Key Pharmaceutical Properties
| Property | Nomegestrol acetate | Estradiol |
|---|---|---|
| Lipophilicity (logP) | ~3.8 | ~2.6 |
| Protein binding | 97–98% (mainly albumin) | ~98% (to SHBG and albumin) |
| Oral bioavailability | ~100% (rapid absorption) | ~95% (but extensive first‑pass hepatic metabolism) |
| Receptor selectivity | High progesterone receptor affinity; antiandrogenic | High oestrogen receptor α/β affinity |
🗒️ Pharmaceutical insight: The combination of estradiol (identical to natural hormone) with nomegestrol acetate offers a more physiological approach to contraception while maintaining high efficacy.
Mechanism of Action: Dual Hormonal Pathway
Zoely exerts its contraceptive effect through three complementary mechanisms, all orchestrated by the synergistic action of nomegestrol acetate and estradiol.
- Ovulation suppression (primary mechanism): Nomegestrol acetate exerts a potent negative feedback on the hypothalamus and pituitary gland. It markedly suppresses the mid‑cycle luteinising hormone (LH) surge, which is essential for ovulation. Estradiol contributes by reducing follicle‑stimulating hormone (FSH) secretion, preventing follicular maturation. This dual suppression results in complete anovulation in the vast majority of cycles.
- Cervical mucus modification: The progestogenic activity of nomegestrol acetate transforms the normally watery, sperm‑permeable cervical mucus into a thick, viscous, and cellular barrier. This change occurs within days of starting treatment and significantly impedes sperm penetration, providing a second line of defence even if ovulation were to occur.
- Endometrial atrophy: Continuous exposure to the progestogen induces a thin, atrophic endometrium that is unfavourable for implantation. This effect is particularly relevant for the rare case of fertilisation, reducing the risk of established pregnancy.
| Feature | Nomegestrol acetate effect | Estradiol effect |
|---|---|---|
| Onset of action | Hours to days (pituitary) | Synergistic with progestogen |
| Duration of effect | Long half‑life (~46 h) ensures sustained suppression | Shorter, but steady state maintained by daily dosing |
| Additional benefits | Antiandrogenic (reduces acne, seborrhoea) | Physiological oestrogen support, good cycle control |
🗒️ Physiological insight: The 24/4 regimen (24 active tablets followed by 4 placebos) mimics the natural menstrual cycle while providing a consistent hormonal milieu that reduces breakthrough bleeding compared to traditional 21/7 regimens.
Absorption & Distribution (Pharmacokinetics)
Following oral administration, both active substances are rapidly absorbed from the gastrointestinal tract. Peak plasma concentrations are reached within 1–2 hours for nomegestrol acetate and estradiol.
Nomegestrol acetate
Absolute bioavailability is nearly 100% due to minimal first‑pass metabolism. Steady state is achieved after 5 days of daily dosing. The volume of distribution is approximately 200 L, indicating extensive tissue distribution. It is highly bound to plasma proteins (97–98%), primarily albumin.
Estradiol
Estradiol undergoes extensive first‑pass metabolism in the gut and liver, converting rapidly to estrone and estrone‑sulfate. Despite this, the daily dose (1.5 mg) achieves steady‑state serum levels comparable to the early follicular phase of the natural cycle. It binds strongly to sex hormone‑binding globulin (SHBG) and albumin.
Metabolic Effects & Elimination
Nomegestrol acetate metabolism: Primarily metabolised in the liver via CYP3A4 and CYP3A5 enzymes to hydroxylated and reduced metabolites, which are pharmacologically inactive. The elimination half‑life is approximately 46 hours, allowing a wide dosing window (up to 24 hours). Excretion is mainly in urine (60–70%) and faeces (30–40%).
Estradiol metabolism: Rapidly metabolised by cytochrome P450 enzymes (CYP3A4, CYP1A2, etc.) to estrone, estriol, and their sulfate and glucuronide conjugates. These metabolites are excreted via urine (60%) and faeces (40%). The half‑life of estradiol is about 16 hours, but its effects are sustained due to the daily dosing.
⚠️ Metabolic caution: Strong CYP3A4 inducers (e.g., rifampicin, St. John’s wort) may accelerate metabolism of both components, reducing contraceptive efficacy. Barrier contraception should be used during concomitant use and for 28 days after stopping the inducer.
Clinical Efficacy in Contraception
Zoely is indicated for oral contraception in women of reproductive age. Its efficacy has been demonstrated in large clinical trials with over 3,000 women. The Pearl Index (number of pregnancies per 100 women‑years) for correct use is <0.4, and the overall Pearl Index (including typical use) is around 0.7–1.0, which is comparable to other combined hormonal contraceptives.
Key efficacy features:
- High contraceptive reliability: When taken as directed (one tablet daily, no missed pills), the ovulation inhibition rate exceeds 99%.
- Cycle control: Withdrawal bleeding occurs in over 95% of women during the 4 placebo days, with a low incidence of breakthrough bleeding after the first few cycles.
- Additional benefits: Due to the antiandrogenic nature of nomegestrol acetate, many users report improvement in acne and seborrhoea. The estradiol component provides a natural oestrogen environment with potentially favourable effects on lipid metabolism compared to ethinylestradiol‑containing pills.
For women switching from another combined pill, Zoely can be started the day after the last active tablet of the previous pack. If a barrier method is needed during the first 7 days, a condom should be used. The 24/4 regimen simplifies adherence and reduces the hormone‑free interval, contributing to steady contraceptive cover.
Zoely FAQs
How long does Zoely take to start working?
If you take Zoely on the first day of your period, it works immediately. If you start between days 2–5 of your cycle, use additional barrier contraception (e.g., condoms) for the first 7 days. After that, protection is continuous.
Can Zoely cause weight gain or acne?
Weight gain is uncommon (affects up to 1 in 10). Nomegestrol acetate has antiandrogenic properties, so it often improves acne rather than worsening it. Some users may experience initial fluid retention, but this usually subsides.
What should I do if I miss a white active tablet?
If you are less than 24 hours late, take it as soon as you remember and continue normally. If you are more than 24 hours late, take the last missed tablet (even if it means taking two), and use a condom for 7 days. If missed in week 1 and had unprotected intercourse, consider emergency contraception.
Is Zoely safe for long‑term use?
Yes, Zoely is suitable for long‑term use if you have no contraindications (e.g., history of blood clots, breast cancer, severe liver disease). Your doctor should review your health annually.
How does Zoely differ from traditional combined pills?
Zoely contains estradiol (identical to natural oestrogen) instead of ethinylestradiol, and a 24‑active‑tablet regimen (shorter hormone‑free interval). This results in a more physiological hormonal profile and improved cycle control.
Need Zoely with Expert Prescribing Advice?
If you are considering Zoely as your contraceptive choice, a UK‑registered doctor can assess your medical history and prescribe it after an online consultation.
Secure Prescription & Next‑Day Delivery
MHRA‑compliant | GPhC‑registered pharmacy | Discreet packaging | UK‑registered doctors
Start Combined Pill ConsultationRelated Zoely Guides
Medical Content Manager
Nabeel is a co-founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.
Medical Doctor
Dr. Feroz is a GMC-registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.
Medical Director
Usman is a co-founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.
Review Date: 22 March 2026
Next Review: 22 September 2026
Published on: 22 March 2026
Last Updated: 22 March 2026